Mitochondrial Genome Deletion Aids in the Identification of False- and True-Negative Prostate Needle Core Biopsy Specimens
about
3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy coresEffect of mtDNA mutation on tumor malignant degree in patients with prostate cancerMultiple strand displacement amplification of mitochondrial DNA from clinical samples.Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0.Performance of mitochondrial DNA mutations detecting early stage cancer.Biomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection.Use of the Prostate Core Mitomic Test in Repeated Biopsy Decision-Making: Real-World Assessment of Clinical Utility in a Multicenter Patient PopulationSmall Circular DNAs in Human Pathology.An empirical assessment of validation practices for molecular classifiersThe awakening of an advanced malignant cancer: an insult to the mitochondrial genomeMitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms.Mitochondrial and nuclear genomics and the emergence of personalized medicineMitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumorsMitochondria and familial predisposition to breast cancer.Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis.Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer.Human mitochondrial DNA: roles of inherited and somatic mutations.Addressing the need for repeat prostate biopsy: new technology and approaches.Somatic Mutation Analyses in Studies of the Clonal Evolution and Diagnostic Targets of Prostate Cancer.Novel biomarkers for prostate cancer: An evidence-based review for use in clinical practice.Risk stratification of prostate cancer 2016.Mitochondria and cancer: past, present, and future.Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men.Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients.An inherited heteroplasmic mutation in mitochondrial gene COI in a patient with prostate cancer alters reactive oxygen, reactive nitrogen and proliferation.Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management.A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients.Tissue-based biomarkers in prostate cancer.A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA 'grey zone'.
P2860
Q24594248-B4F5BAA0-1E0B-458B-ADDE-CC9B50FB0AF5Q28272506-0F6A7015-A4D4-4DE3-AD1A-6B2757CE2BEEQ33318717-39F60389-8B82-4B31-80A4-DE1DFF440330Q33327587-484EFC64-4E1C-4E96-9A32-CB9192047539Q33373844-0FF54AD2-28F0-4869-94A4-2C8D94D73E31Q33520448-515ECEE9-D392-4CA0-9C18-566218C20DD9Q33572829-D765F751-DA8D-411E-BAA8-D0A8F61DD4E5Q34178090-C46B9C91-DF77-4E19-BA26-BA86EEA69FA1Q34933977-57D47654-EA91-4C26-969D-61F0692D500AQ35718294-1CB0436D-4E1B-44E3-BFCF-DA5E874298E0Q35815831-A2076809-1E29-44FC-A4EF-BB7AB3ED629AQ36220588-4BFB2F19-E21B-49B6-82A8-45DE22340D22Q36235955-31B9A7EF-5946-4782-8846-072217BBFFE8Q36877040-4E49C9C7-A135-4BE8-9A8B-678FD269242BQ37521873-B3C87C92-AF02-4856-8EEF-91E0604C0AA6Q37538185-3E5104E4-2F52-4334-98CF-4E50F55D79FDQ37648855-7813EEF8-D9A3-471C-87CA-E5F2EFB84218Q38546671-2930622C-9EAA-4EF1-943E-7E245CAACF08Q38703676-59541A7D-7FB4-4512-A9C2-9F3FE92DB053Q38874800-5F773A2A-C8B9-42C7-86B3-F82F55D48854Q38929868-8ABF15C9-DCC6-47F9-B1BF-691D1D40C7FEQ39448724-F645D9C0-607A-4572-BF7D-7E12BF9ABA65Q40197058-C8524816-61CF-4555-88F0-3F20F8FACF2EQ41205889-20E3238F-E4ED-4F91-935E-5799294C197DQ41957650-00E5B9C0-1521-4904-9B04-51250A5FBE2DQ42378534-F4A50883-7AEF-4C8F-BC37-87246D8E4C03Q43083508-3A3FF1E2-6FCC-4600-B7A3-710E3E3463F4Q47144748-6A2281DD-222C-4335-8298-C62FD4473D0FQ49719286-74E2DB70-434D-4234-B8A7-13634B312FCE
P2860
Mitochondrial Genome Deletion Aids in the Identification of False- and True-Negative Prostate Needle Core Biopsy Specimens
description
article
@en
im Januar 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2008
@uk
name
Mitochondrial Genome Deletion ...... e Needle Core Biopsy Specimens
@en
Mitochondrial Genome Deletion ...... e Needle Core Biopsy Specimens
@nl
type
label
Mitochondrial Genome Deletion ...... e Needle Core Biopsy Specimens
@en
Mitochondrial Genome Deletion ...... e Needle Core Biopsy Specimens
@nl
prefLabel
Mitochondrial Genome Deletion ...... e Needle Core Biopsy Specimens
@en
Mitochondrial Genome Deletion ...... e Needle Core Biopsy Specimens
@nl
P2093
P356
P1476
Mitochondrial Genome Deletion ...... e Needle Core Biopsy Specimens
@en
P2093
Andrea Aguirre
Anthony Skehan
Brian Reguly
Gabriel D. Dakubo
Jennifer Maki
John P. Jakupciak
Jude Alexander
Kerry Robinson
M. Kent Froberg
Michael J. Wilson
P356
10.1309/UJJTH4HFEPWAQ78Q
P407
P577
2008-01-01T00:00:00Z